Reversal of Imatinib resistance in BCR-ABL-positive leukemia after inhibition of the Na+/H+ exchanger

被引:19
作者
Jin, Weina [1 ,2 ,3 ]
Li, Qinghua [1 ,2 ,3 ]
Lin, Yani [1 ,2 ,3 ]
Lu, Ying [1 ,2 ,3 ]
Li, Huawen [1 ,2 ,3 ]
Wang, Lihong [1 ,2 ,3 ]
Hu, Ronghua [1 ,2 ,3 ]
Ma, Li [1 ,2 ,3 ]
Wang, Jianxiang [1 ,2 ,3 ]
Pang, Tianxiang [1 ,2 ,3 ]
机构
[1] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China
[2] Chinese Acad Med Sci, Hosp Blood Dis, Tianjin 300020, Peoples R China
[3] Peking Union Med Coll, Tianjin 300020, Peoples R China
关键词
BCR-ABL; P-glycoprotein; Na+/H+ exchanger 1; Intracellular pH; Mitogen-activated protein kinase; CHRONIC MYELOGENOUS LEUKEMIA; JUN NH2-TERMINAL KINASE; BREAST-CANCER CELLS; P-GLYCOPROTEIN; C-JUN; SIGNAL-TRANSDUCTION; DOWN-REGULATION; EXPRESSION; PATHWAY; OVEREXPRESSION;
D O I
10.1016/j.canlet.2011.04.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study was undertaken to estimate the therapeutic benefit to down-regulate the Na+/H+ exchanger 1 (NHE1) for reversing chemoresistance of BCR-ABL-positive leukemia patient cells and cell lines. As a result, after treatment with specific NHE1 inhibitor Cariporide or high K+ buffer to decrease intracellular pH (pH(i)), cells from relapsed patients exhibited decreased Pgp level, enhanced Rhodamine123 and drug accumulation, decreased colony-forming ability and the modulations of mitogen-activated protein kinases (MAPKs) activities. Furthermore, we used BCR-ABL-positive cell line K562 and its resistant counterparts K562/DOX and K562/G01 cell lines for further study. Together, these findings suggest that Pgp may be associated with the reversal of drug resistance in BCR-ABL-positive leukemia patients and cell lines by the inhibition of NHE1 though MAPK pathways. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:81 / 90
页数:10
相关论文
共 27 条
[1]   The functional contrariety of JNK [J].
Bode, Ann M. ;
Dong, Zigang .
MOLECULAR CARCINOGENESIS, 2007, 46 (08) :591-598
[2]   Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2 [J].
Esparís-Ogando, A ;
Díaz-Rodríguez, E ;
Montero, JC ;
Yuste, L ;
Crespo, P ;
Pandiella, A .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (01) :270-285
[3]   Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification [J].
Gorre, ME ;
Mohammed, M ;
Ellwood, K ;
Hsu, N ;
Paquette, R ;
Rao, PN ;
Sawyers, CL .
SCIENCE, 2001, 293 (5531) :876-880
[4]   Molecular and chromosomal mechanisms of resistance to imatinib (ST1571) therapy [J].
Hochhaus, A ;
Kreil, S ;
Corbin, AS ;
La Rosée, P ;
Müller, MC ;
Lahaye, T ;
Hanfstein, B ;
Schoch, C ;
Cross, N ;
Berger, U ;
Gschaidmeier, H ;
Druker, BJ ;
Hehlmann, R .
LEUKEMIA, 2002, 16 (11) :2190-2196
[5]   P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate [J].
Illmer, T ;
Schaich, M ;
Platzbecker, U ;
Freiberg-Richter, J ;
Oelschlägel, U ;
von Bonin, M ;
Pursche, S ;
Bergemann, T ;
Ehninger, G ;
Schleyer, E .
LEUKEMIA, 2004, 18 (03) :401-408
[6]   Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein [J].
Katayama, Kazuhiro ;
Yoshioka, Sho ;
Tsukahara, Satomi ;
Mitsuhashi, Junko ;
Sugimoto, Yoshikazu .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (07) :2092-2102
[7]   Chronic myelogenous leukaemia [J].
Lee, SJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (04) :993-1009
[8]   PO2-dependent differential regulation of multidrug resistance 1 gene expression by the c-jun NH2-terminal Kinase pathway [J].
Liu, Min ;
Li, Dengwen ;
Aneja, Ritu ;
Joshi, Harish C. ;
Xie, Songbo ;
Zhang, Chao ;
Zhou, Jun .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (24) :17581-17586
[9]  
Lu Ying, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P568
[10]   Down-regulation of P-glycoprotein expression by sustained intracellular acidification in K562/DOX cells [J].
Lu, Ying ;
Pang, Tianxiang ;
Wang, Jianxiang ;
Xiong, Dongsheng ;
Ma, Li ;
Li, Bin ;
Li, Qinghua ;
Wakabayashi, Shigeo .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 377 (02) :441-446